Short Interest in Movano Inc. (NASDAQ:MOVE) Rises By 39.6%

Movano Inc. (NASDAQ:MOVE) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 29,600 shares, a growth of 39.6% from the September 30th total of 21,200 shares. Based on an average daily volume of 235,600 shares, the short-interest ratio is currently 0.1 days. Approximately 4.9% of the company’s shares are short sold. Approximately 4.9% of the company’s shares are short sold. Based on an average daily volume of 235,600 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Hedge Funds Weigh In On Movano

An institutional investor recently raised its position in Movano stock. Baird Financial Group Inc. grew its position in Movano Inc. (NASDAQ:MOVE) by 3.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 323,943 shares of the technology company’s stock after buying an additional 11,366 shares during the period. Baird Financial Group Inc. owned approximately 4.60% of Movano worth $593,000 at the end of the most recent quarter. Institutional investors and hedge funds own 16.64% of the company’s stock.

Movano Stock Performance

Shares of Movano stock opened at $5.20 on Wednesday. The firm has a fifty day moving average of $7.06 and a two-hundred day moving average of $7.13. The stock has a market capitalization of $4.32 million, a price-to-earnings ratio of -0.13 and a beta of 0.85. Movano has a 52 week low of $5.10 and a 52 week high of $69.68.

Movano Company Profile

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.